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Background: Staphylococcus aureus is a human pathogen responsible for substantial morbidity and mortality
through its ability to cause a number of human infections including bacteremia, pneumonia and soft tissue
infections. Of great concern is the emergence and dissemination of methicillin–resistant Staphylococcus aureus
strains (MRSA) that are resistant to nearly all β-lactams. The emergence of the USA300 MRSA genetic background
among community associated S. aureus infections (CA-MRSA) in the USA was followed by the disappearance of
USA400 CA-MRSA isolates.
Results: To gain a greater understanding of the potential fitness advantages and virulence capacity of S. aureus
USA300 clones, we performed whole genome sequencing of 15 USA300 and 4 USA400 clinical isolates. A
comparison of representative genomes of the USA300 and USA400 pulsotypes indicates a number of differences in
mobile genome elements. We examined the in vitro gene expression profiles by microarray hybridization and the
in vivo transcriptomes during lung infection in mice of a USA300 and a USA400 MRSA strain by performing
complete genome qRT-PCR analysis. The unique presence and increased expression of 6 exotoxins in USA300
(12- to 600-fold) compared to USA400 may contribute to the increased virulence of USA300 clones. Importantly,
we also observed the up-regulation of prophage genes in USA300 (compared with USA400) during mouse lung
infection (including genes encoded by both prophages ΦSa2usa and ΦSa3usa), suggesting that these prophages
may play an important role in vivo by contributing to the elevated virulence characteristic of the USA300 clone.
Conclusions: We observed differences in the genetic content of USA300 and USA400 strains, as well as significant
differences of in vitro and in vivo gene expression of mobile elements in a lung pneumonia model. This is the first
study to document the global transcription differences between USA300 and USA400 strains during both in vitro
and in vivo growth.Background
Methicillin-resistant Staphylococcus aureus (MRSA) iso-
lates have emerged as a leading cause of infectious diseases
[1-6]. Once confined primarily to hospitals and patients
with defined risk factors, infections caused by community-
associated MRSA (CA-MRSA) isolates have become epi-
demic in the United States and now frequently occur* Correspondence: mjones@jcvi.org
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unless otherwise stated.among previously healthy individuals without these risk
factors [7,8]. Although the majority of CA-MRSA infec-
tions are mild, some CA-MRSA infectious syndromes such
as complicated skin and soft tissue infections, necrotizing
pneumonia, bacteremia, and sepsis can be life-threatening
[7-10]. After the first report of CA-MRSA deaths in
children in it became recognized that the strain type was
USA400 [11-14]. During the early emergence of CA-
MRSA, isolates of both MRSA and MSSA with the
USA400 pulsed field pattern were identified as causes of
severe sepsis and death characterized by rapidlyhis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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pneumonia and multiple-organ-system involvement and
bilateral adrenal hemorrhage characteristic of the
Waterhouse–Friderichsen syndrome [14]. However, among
community associated MRSA infections, USA400 has been
nearly completely replaced by another CA-MRSA back-
ground, called USA300 [15-23]. The reasons for the re-
placement of USA400 by USA300 are not known.
Many have speculated that the dominance of USA300
is evidence of altered fitness. In support of this notion,
USA300 strains are hypervirulent, compared with USA400
strains, in several animal models of skin infection and
pneumonia [24]. Although the relationship between fitness
and virulence is not clear, understanding the mechanisms
of the extraordinary virulence of USA300 strains will shed
light onto the reasons for its emergence. The virulent na-
ture of S. aureus is mediated by a wide array of cell surface
proteins, secreted toxins and mobile genetic elements [15,
25-31]. As such there are at least two possible explana-
tions for the virulence of USA300. One is that USA300
strains have acquired novel genomic content that en-
hances its fitness and/or virulence. For example, among
sequenced S. aureus isolates, the arginine catabolic mobile
element (ACME) is present in most USA300 strains circu-
lating in the United States, but not USA400 isolates [22].
ACME is a large mobile genetic element also found in
some Staphylococcus epidermidis isolates encoding at
least 33 open reading frames [22,32]. Deletion of ACME
from USA300 enhanced survival in a rabbit model of
bacteremia [32], but ACME was not necessary for viru-
lence in rodent models of pneumonia or skin infection
[33]. However, ACME encodes an arginine deiminase
gene, called arcA that allows for enhanced survival in
acidic environments [34]. Interestingly, this process
drives the synthesis of host polyamines that are toxic to
S. aureus. It is likely not a coincidence that ACME
therefore also encodes a spermine acetyl transferase,
speG, which counteracts the toxic effects of polyamines.
In this regard, ACME appears to at least partially account
for the observed pathogenesis of USA300 in skin infection
[35,36]. Nevertheless, ACME-deficient USA300 clinical
isolates have been described supporting the data from ani-
mal models that ACME is not a necessary component of
pathogencity or survival in humans.
An alternative explanation is that USA300 has evolved
to alter the expression/activity of S. aureus regulatory
genes that are part of the core genome. In support of
this idea, USA300 isolates have increased expression of
the global regulatory systems agr and saeRS, and attend-
ant increased expression of downstream toxins such as
the Panton-Valentine leukocidin (PVL, encoded by lukSF-
PV), the alpha-hemolysin (Hla, encoded by hla), and
phenol soluble modulins (PSMs), compared to USA400
[24,37,38]. Although there is a strong epidemiologicassociation of PVL carriage with severe disease caused by
CA-MRSA, its role in pathogenesis is controversial. Since
PVL is present in both USA300 and USA400 isolates, it is
not likely that its presence accounts for the differences in
virulence between the genomic backgrounds. In contrast,
agr, saeRS, hla and the PSMs which are core genes present
in almost all S. aureus strains, clearly advance the
pathogenesis of USA300 in animal models [37,39,40].
Although it is known that USA300 has altered regula-
tion of selected global regulators and virulence genes
compared with USA400, it is not known whether there
are global differences in the transcription profiles be-
tween USA300 and USA400.
By comparing the in vitro transcriptional profiles of
USA300 and USA400 using DNA microarray technol-
ogy, we tested our hypothesis that USA300 strains have
global regulatory alterations that contribute to their hy-
pervirulent phenotype. To identify the possibility that
the in vivo environment in host tissues can influence
bacterial gene expression, we quantified bacterial gene
expression in the lungs of animals infected with MRSA
strains USA300 and USA400. Together our data offer a
glimpse into CA-MRSA USA300 and USA400 pathogen-
esis and suggest a potential model for the observed in-
creased virulence of S. aureus USA300 strains.
Results
Genomic characterization of USA300 and USA400 strains
To better understand the genomic diversity of USA300
and USA400 strains and the features that distinguish
these two lineages, 15 USA300 clinical isolates and 4
USA400 isolates (Table 1) were sequenced using Roche
454 FLX sequencing technology. The completely se-
quenced USA300_FPR3757 strain was used as a reference
for comparison to USA300 isolates, whereas USA400
strains were compared to S. aureus USA400 strain MW2.
These comparisons allowed us to identify 2,279 genes that
are uniformly conserved between all of the sequenced
USA300 and USA400 isolates. The number of genes
unique to either lineage was similar. USA400 genomes
uniquely encode 57 genes (Additional file 1: Table S1)
across all isolates, whereas USA300 isolates uniquely en-
code 46 genes (Additional file 2: Table S2) across all iso-
lates. These genes were examined in greater detail by
assessing their predicted functional roles. Novel genes
present in USA300 include a toxin-antitoxin system, the
chemotaxis-inhibiting protein (CHiPS), and a number of
hypothetical proteins in the ΦSa3usa phage. Each of these
sequences displays an overall strong conservation within
USA300 isolates. Specifically, there were 35 genes that
were unique to USA300 isolates compared to USA400 iso-
lates in the ΦSa3usa phage, as well as the ACME element.
All USA300 and 400 isolates were also compared to a var-
iety of S. aureus sequence-types in a PanGenome analysis
Table 1 USA300 and USA 400 isolates
USA Pulsotype Strain name ST coverage Year Site of isolation or syndrome Onset SRA ID
USA400 staph649 ST1 99.02 2004 Skin infection CA SRX026443
USA400 gsast11506 ST1 99 2000 CA SRX026318
USA400 gsast2674 ST1 99 2000 Respiratory, severe sepsis nec pneumonia CA SRX025928
USA400 gsastq2352 ST1 99 2000 Respiratory, severe sepsis nec pneumonia CA SRX025931
USA300 gsast10243 ST8 98.15 2007 Blood CA SRX026310
USA300 gsast10329 ST8 99.27 2007 Peritoneal/body fluid HA SRX026315
USA300 gsast1135 ST8 98.15 2004 Skin infection CA SRX026317
USA300 gsast11578 ST8 99.3 2002 CA SRX025942
USA300 gsast1185 ST8 96.65 2004 Skin infection CA SRX025925
USA300 gsast13205 ST8 97.37 2008 Blood, nec pneumonia, sepsis SRX025943
USA300 gsast2145 ST8 99.28 2005 Skin infection CA SRX026311
USA300 gsast5319 ST8 99.32 2005 Skin infection CA SRX026314
USA300 gsast9376 ST8 97.91 2007 Respiratory HA SRX025927
USA300 gsast9549 ST8 99.26 2007 Screen HA SRX025926
USA300 gsast9636 ST8 99.28 2007 Respiratory HA SRX025944
USA300 gsast9750 ST8 98.82 2007 Screen HA SRX025939
USA300 gsastca11 ST8 95.94 1998 CA SRX025929
USA300 staph923 ST8 99.31 2004 Skin infection CA SRX025930
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Additional file 5: Figure S1). Pangenome analysis revealed
2 major branches (Additional file 5: Figure S1). These
branches demonstrate strong clustering of our USA300
and USA400 lineages, compared to other sequence-type
(Additional file 3: Table S3). Genes specific to the USA300
lineage appear to be associated with bacteriophage and
mobile genomic elements present in USA300 that are
absent in the USA400 lineages. Furthermore, kSNP ana-
lysis of core genes within our USA300 and 400 lineages
(Additional file 6: Table S5; Additional file 7: Figure S2)
demonstrate a strong correlation with S. aureus strain
sequence type.
In vitro differential gene expression between USA300 and
USA400 isolates
In order to test our hypothesis that USA300 and USA400
strains differ in their global gene expression patterns, we
compared global gene expression between a clinical
USA300 isolate (strain 923) and a clinical USA400 isolate
(strain 649) using DNA microarrays. We compared gene
expression patterns of cells grown in TSB medium at 30,
60, 90, and 120 minutes of growth. An analysis of signifi-
cant differences in gene expression using SAM revealed
480 genes (342 genes more highly expressed in USA300
isolate and 138 genes more highly-expressed in the
USA400 strain. Role category analysis of genes consid-
ered to be part of the shared core USA300/USA400 ge-
nomes demonstrated an overall higher gene-expression
profile in most functional categories in the USA300isolate compared with the USA400 isolate (Figure 1).
The USA300 isolate displayed increased expression for
genes encoding cell envelope proteins (including several
lipoproteins and superantigen-like proteins) and a large
number of hypothetical and genes of unknown function
compared with the USA400 isolate 649. Interestingly,
genes belonging in mobile elements were more highly
expressed in the USA400 strain compared to the USA300
isolate.
Among the genes with differential expression between
the strains, there is higher expression in transcription of
regulatory genes including agrBDC and rot, and differen-
tial expression of the two prophages present in the ge-
nomes of the sequenced USA300 and USA400 genomes.
Interestingly, among the genes deemed significantly differ-
entially expressed that reside in the prophage ΦSa2usa
(Additional file 8: Table S6), 20 were more highly
expressed in the USA400 isolate, whereas 6 genes were
more highly expressed in the USA300 strain. In contrast,
the genes residing in prophage ΦSa3usa were highly
expressed in the USA300 strain and not detected in the
USA400 strain (Additional file 9: Table S7). This is con-
sistent with the fact that the prophage ΦSa3usa insertion
was only found to be present in the USA300 isolate and
absent in the USA400 isolate, which is consistent with the
reference USA300 and USA400 genomes.
Analysis of genes known to play a role in neutrophil eva-
sion functions displayed differential expression (Additional
file 10: Table S8). Genes that had significantly higher
expression in the USA300 isolate compared with the
Figure 1 Role category analysis of S. aureus USA300 and USA400 genes differentially expressed in vitro and in vivo growth. X- axis
represents individual role categories based on gene function. Y-axis values indicate the mathematical difference in the number of genes
significantly differentially expressed between USA300 and USA400 isolates during in vitro and in vivo growth. Positive values indicate a higher
number of genes differentially expressed in the corresponding role category in USA300 isolate 923 compared to USA400 isolate 649. Negative
values indicate a higher number of genes differentially expressed in the corresponding role category in USA400 isolate 649 compared to USA300
isolate 923. Blue bars indicate values from the 30 min in vitro time point; Yellow bars indicate 60 min in vitro time point; Green bars indicate
90 min in vitro time point; Maroon bars indicate 120 min in vitro time point; and Red bars indicate bars indicate the in vivo time point.
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protein A precursor (SAUSA300_0113), fibrinogen-
binding protein (SAUSA300_1055), superantigen-like
protein (SAUSA300_0407) and a leukocidin family pro-
tein (SAUSA300_1975). Several genes encoded in the
pathogenicity islands vSAα and vSAβ also more highly
expressed in the USA300 isolate Additional file 11:
Table S9). Interestingly, compared with USA400, we ob-
served an overall reduced expression of genes located in
the S. aureus pathogenicity island SaPI5, with the excep-
tion of the gene encoding the ear exoprotein that is associ-
ated with virulence in USA300. There were also a number
of lipoproteins and proteases more highly expressed in the
USA300 isolate compared with USA400 strain. The gene
encoding the IgG binding protein, Sbi, displayed slightly
increased expression in the USA300 isolate. Surprisingly,expression of agrA and the δ-hemolysin were more highly
expressed in the USA400 strain. Other genes of interest
that were more highly expressed in the USA400 strain in-
cluded two antibacterial proteins and lukF-PV.
In vivo differential gene expression comparison of
USA300 and USA400
Because it is not known if in vitro gene expression corre-
lates with that seen in vivo, we sought to determine the
differential expression of USA300 and USA400 isolates
in vivo in a mouse model of lung infection by using
complete genome qRT-PCR analysis. We chose to assess
in vivo expression of bacteria during infection of lungs
of mice 4 hours after inoculation with S. aureus because
the number of bacteria recovered from the lungs at this
time point is the same, regardless of the infecting isolate,
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is before the onset of mortality. Consistent with this, all
infected animals appeared ill at 6 hours post-infection.
Our results recapitulate other virulence studies as,
nearly all (4/5) mice infected with USA300 strains died
within 24 to 48 hours after inoculation, whereas none
(0/5) of the mice infected with USA400 strains died.
When using a cutoff of two-fold change in expression,
we observed 624 genes with higher expression in the
USA300 isolate compared to 1075 genes displaying ele-
vated expression in the USA400 strain. Among these
USA300 genes were encoded in ACME, the prophages
ΦSA2usa and ΦSA3usa, the pathogenicity islands vSAα
and vSAβ, and genes arcC, argR, and coa. These data
suggest that, although the USA300 isolate has increased
in vitro expression compared with USA400 strains, the
converse is true in vivo (Figure 1).
As we observed in the in vitro expression analysis, there
were striking differences in the expression of the prophages
ΦSA2usa and ΦSA3usa between USA300 and USA400
in vivo (Additional file 8: Table S6 and Additional file 9:
Table S7). In concordance with the in vitro data, genes
in ΦSA3usa were more highly expressed during lung in-
fection in the USA300 isolate compared with the USA400
strain. However, whereas genes encoded in ΦSA2usa were
generally expressed at higher levels in USA400 compared
with USA300 in vitro, the in vivo expression was generally
higher in the USA300 isolate. This suggests that in vivo
cue(s), and a potentially novel signal transduction net-
work, is required for full expression of ΦSa2usa, and other
virulence genes, in S. aureus USA300.
The in vivo expression of genes contained in ACME
was detected in lungs infected with USA300 but not
USA400. This was expected and validates our DNA se-
quence data showing that ACME is not present in the
USA400 strain. As we observed in vitro, there were a
number of lipoproteins whose expression during lung in-
fection was higher in USA300 compared with USA400.
Interestingly, there was strongly induced expression of
the epidermin immunity protein operon after infection
with USA300, compared with USA400. This operon has
been previously associated with increased fitness of CA-
MRSA strains due to its role in lantibiotic resistance
[41]. Notably, there was also higher expression of a clus-
ter of urease genes in USA300 during infection of lungs
compared with USA400. These genes have been demon-
strated to be induced during acid shock, and may serve
as a mechanism to neutralize acidification of the phagoly-
sosomal compartment and promote intracellular survival
[42]. Among the genes in USA400 whose expression in-
creased during lung infection compared with USA300, we
were surprised to find the two-component global regula-
tory system saeRS and δ-hemolysin, in part, which is
under the control of the agr effector, RNAIII. There wasalso increased in vivo expression of the toxin encoding
genes hla, hlb, and hlc in USA400 strain (Additional file
10: Table S8).
Discussion
USA300 MRSA isolates have emerged as the dominant
cause of CA-MRSA infections in the United States.
However, it has been unclear why USA300 has replaced
its predecessor (USA400) in CA-MRSA infection. Fur-
thermore, understanding the rapid evolution that led to
increased virulence of S. aureus USA300 isolates, com-
pared with highly virulent USA400 isolates, can inform
better strategies for treating and preventing CA-MRSA
infections. Previous work has suggested that the in-
creased virulence of USA300 isolates might be due to in-
creased expression of global regulators and toxin genes
[24]. Although this would explain the hypervirulent pheno-
type of USA300 isolates, the relationship between virulence
and fitness is less well understood. In an effort to under-
stand the contribution of genetic factors that contribute to
the success of USA300, we performed comparative genome
sequencing of USA300 and USA400 isolates, in vitro gene
expression analysis, and assessed in vivo gene expression
by means of complete genome qPCR in an established
mouse model of S. aureus necrotizing pneumonia.
Analysis of the sequenced isolates revealed a strong
conservation of genes between ST1 (USA400) and ST8
(USA300) isolates as expected. However, genes that were
deemed unique to USA300 isolates include genes encoded
in the ACME element, the prophage ΦSA3usa and a
toxin-antitoxin system. However, many of these genes are
not functionally characterized and are annotated as hypo-
thetical with no defined function. It is well documented
that mobile elements often encode genes that provide a
fitness advantage in the form of antibiotic resistance deter-
minants, toxins and intracellular survival determinants. It
is plausible that many of the hypothetical genes we identi-
fied that are unique to USA300 isolates may have provided
an in vivo fitness advantage and increased the virulence
compared with USA400 and other S. aureus isolates.
Although S. aureus gene expression was globally higher
in isolate USA300 compared with USA400 in vitro, ex-
pression was globally higher in vivo during lung infection
in USA400 isolate 649 compared with USA300 isolate
923. In some cases, there was higher expression of lipo-
proteins in USA300 compared with USA400 during infec-
tion, just as there was in vitro. Expression of the ACME
element was also increased in USA300 after infection,
compared with USA400; this was expected because
ACME is only present in USA300 but it serves as a valid-
ation of the experiment. There was also increased expres-
sion of agrB, agrD, and ΦSA3usa in USA300 during
infection of lungs compared with USA400, in concordance
with the in vitro data. Also to note was the increased
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USA300 during in vitro growth. Previously, we observed
increased in vitro expression of both agrA and hla in
USA300 compared with USA400, however that observa-
tion was at a later time point during infection [39].
On the other hand, expression of saeRS and δ-
hemolysin (encoded within agr) was higher in USA400
during infection compared with USA300. Both sae and
agr are necessary for virulence in S. aureus necrotizing
pneumonia caused by USA300 and it is likely that these
are also important in USA400 necrotizing pneumonia
[43]. There was also increased expression of the agr-
and saeRS- controlled toxin genes hla, lukS-PV, and 2
PSMs in USA400 compared with USA300 during infec-
tion. Although USA400 has a higher LD50 than USA300
in rodent experimental models, it is nevertheless capable
of producing a high mortality rate in groups of mice in-
fected at its lethal dose [24]. Moreover, when USA400
was still in circulation among humans in the United
States, it was highly virulent as it was recognized for
causing severe sepsis and rapidly progressive disease
leading to death [14]. Therefore, The finding that agr-
and saeRS- controlled toxin genes hla, lukS-PV, and 2
PSMs were expressed at higher levels in USA400 in this
study reinforces the observation that USA400 was a
virulent strain of S. aureus in humans. We note that our
study is a single time point, and S. aureus gene expression
may differ significantly at different stages of growth/infec-
tion [44].
One possible scenario for the discordance in S. aureus
gene expression during in vitro and in vivo growth is the
absence of complex host/immune factors that act as en-
vironmental cues resulting in modulation of S. aureus
gene expression. Data generated from in vitro growth con-
ditions have provided the wealth of knowledge that has
given the scientific community the foundation required to
understand the complex regulatory networks that modu-
late signaling/expression pathways. However, conclusions
drawn from in vitro gene expression studies must be inter-
preted with caution as numerous details of the S. aureus
transcriptome may differ significantly between in vitro
and in vivo growth as our study attests. Thus, effort must
be made to measure virulence gene expression of signal
transduction networks directly from infection models
using approaches similar to the one described in this study
if we are to identify vaccine targets relevant to infection.
An intriguing possibility of the features bestowed to
USA300 strains to be successful may be related to in-
creased emphasis on immune evasion during infection.
This hypothesis is supported by the increased expression
of ΦSA3usa observed after infection with USA300 com-
pared with USA400. ΦSA3usa encodes a number of im-
mune evasion genes, including CHIPs and staphylokinase
[22]. There was also higher expression of the epiderminimmunity protein operon in USA300 during infection,
compared with USA400. This cluster of genes has been
previously associated with increased fitness of CA-MRSA
strains due to its role in lantibiotic resistance. Along these
lines, there was higher expression of genes encoding ure-
ase subunits and metabolism in USA300 during infection
compared with USA400. These genes have been demon-
strated to be induced during acid shock, and may serve
as a mechanism to neutralize acidification of the phago-
lysosome and promote intracellular survival and fitness.
Therefore, USA300 may exploit increased urease activ-
ity under low pH, to neutralize the phagolysosomal
compartment, allowing USA300 isolates to survive an
acute immune response and may explain why USA300
is associated with persistent and recurrent infections.
Our hypothesis is supported by recent observation of a
S. aureus strain that inhibits acidification of a phagoly-
sosome following phagocytosis [45].
Conclusion
Our findings have important implications in the charac-
terization of pathogenesis and virulence effectors in S. aur-
eus. The discordant findings between the in vitro and
in vivo settings suggest that studies to characterize S. aur-
eus virulence should attempt to mimic the hostile host en-
vironment (e.g. pH shock); and must be comparatively
analyzed with ex vivo and in vivo time-course models to
fully reconstruct the arsenal of virulence factors and patho-
genesis of S. aureus. Complete understanding of the host-
pathogen signal interaction during acute and persistent
infections is critical for the treatment and prevention of
CA-MRSA and all other S. aureus infections. In summary,
there are differences in the genetic content of USA300 and
USA400 strains. This is the first study to document the
global transcription differences between USA300 and
USA400 strains during both in vitro and in vivo growth.
Methods
Bacterial strains
Strain 649 is a well characterized USA400 MRSA isolate
(SCCmec type IV, pvl+) that belongs to multilocus se-
quence type (ST) 1. This isolate was obtained from the
respiratory tract of an infant with necrotizing pneumo-
nia who died of severe sepsis [12, 14]. Strain 923 is a
USA300 MRSA isolate (SCCmec type IV+, pvl+) that be-
longs to ST8 [46] and carries the arginine catabolic mo-
bile element (ACME) [33]; it was obtained from a skin
abscess. Strain 923 is more virulent than strain 649 in
lung and skin infection rodent models [24]. Additional
strains sequenced are shown in Table 1.
Genome sequencing and assembly
All strains were grown in tryptic soy broth (TSB) and
genomic DNAs were isolated. All genomic DNAs were
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The sequences of strains USA300 and USA400 were as-
sembled using Newbler from the Roche 454 software
suite. Quality assessment of the assembled genomes was
based on depth of coverage calculated from the ACE
files and also breadth of coverage by mapping to their
respective reference genomes. All strains were annotated
using the Manatee tool developed at JCVI. All reads
were submitted to SRA (Table 1.)
Bacterial growth and RNA isolation from in vitro growth
S. aureus RNA was isolated from in vitro bacterial cul-
tures grown in TSB at 30, 60, 90 and 120 minutes post
inoculation. Two volumes of RNA protect (Qiagen) was
directly added to the growth media and subsequently
pelleted and stored at −20°C until RNA extraction, using
the Ambion mirVana RNA kit (Austin, TX). RNA quan-
tity and quality was assessed by measuring total RNA on
a nanodrop and visualizing RNA on an agarose gel. Puri-
fied RNA was stored at −80°C. Murine lungs harvested
from infected mice were homogenized in the Ambion
Mirvana lysis-binding buffer and further extracted using
the PCT pressure cycler (Pressure Biosciences). Total
RNA was extracted from homogenized and lysed tissues
as described by the manufacturer (Ambion).
Generation of probes for microarray experiments,
microarray hybridization, normalization and data analysis
DNA probes for microarray experiments were generated
by adding 2 μg of total RNA to a mixture containing 6 μg
of random hexamers (Invitrogen), 0.01 M dithiothreitol,
an aminoallyl-deoxynucleoside triphosphate mixture con-
taining 25 mM each dATP, dCTP, and dGTP, 15 mM
dTTP, and 10 mM amino-allyl-dUTP (aa-dUTP) (Sigma),
reaction buffer, and 400 units of SuperScript III reverse
transcriptase (Invitrogen) at 42°C overnight. The RNA
template was then hydrolyzed by adding NaOH and
EDTA to a final concentration of 0.2 and 0.1 M, respect-
ively, followed by incubatation at 70°C for 15 min.
Unincorporated aa-dUTP was removed with a QIA-
quick column (Qiagen). The probe was eluted with PE
buffer (4 mM KPO4, pH 8.5, in ultrapure water), dried
to completion, and resuspended in 0.1 M sodium car-
bonate buffer (pH 9.0). To couple the amino-allyl cDNA
with fluorescent labels, Cy3 or Cy5 mono-reactive dye
(Amersham) was added for 1 h. Uncoupled label was re-
moved using the Qiagen QIAquick PCR purification kit
(Valencia, CA).
Aminosilane-coated slides representing a set of 4,589
S. aureus unique open reading frame sequences derived
from seven reference genomes and plasmid, pLW043
(www.jcvi.org) were prehybridized in 5× SSC (1× SSC is
0.15 M NaCl plus 0.015 M sodium citrate) (Invitrogen),
0.1% sodium dodecyl sulfate, and 1% bovine serumalbumin at 42°C for 60 min. The slides were then washed
at room temperature with distilled water, dipped in isopro-
panol, and allowed to dry. Equal volumes of the appropri-
ate Cy3- and Cy5-labeled probes were combined, dried
and resuspended in a solution of 40% formamide, 5× SSC,
and 0.1% sodium dodecyl sulfate. Resuspended probes
were heated to 95°C prior to hybridization. The probe mix-
ture was then added to the microarray slide and allowed to
hybridize overnight at 42°C. Hybridized slides were washed
sequentially in solutions of 1x SSC-0.2% SDS, 0.1× SSC-
0.2% SDS, and 0.1× SSC at room temperature, then
dried in air, and scanned with an Axon GenePix 4000
scanner. Agilent hybridizations were performed as de-
scribed by the manufacturer. Individual TIFF images from
each channel were analyzed with TIGR Spotfinder (avail-
able at http://sourceforge.net/projects/mev-tm4/files/mev-
tm4/). Microarray data were normalized by LOWESS in
TIGR MIDAS software (available at http://sourceforge.
net/projects/mev-tm4/files/mev-tm4/). All gene expres-
sion data is publicly available at GEO under GSE26255.
Mouse infection model
All animal experiments were approved by the Institu-
tional Committee on the Care and Use of Animals at the
University of Chicago. Our mouse model of S. aureus nec-
rotizing pneumonia has been described [39]. Briefly, bac-
teria were subcultured from frozen stocks onto tryptic soy
agar (TSA) and incubated overnight at 37°C. The follow-
ing evening, one colony was subcultured in 5 ml TSB and
incubated overnight with shaking (250 rpm) at 37°C. The
following morning, the overnight culture was diluted
1:100 in fresh TSB (flask:volume ratio 7:1) and grown to
mid-exponential phase. The bacteria were pelleted by
centrifugation (4000 × g, 15 min), washed in sterile PBS,
and resuspended in PBS to a final concentration of 2 ×
108 CFU/20 μl. The inoculum was confirmed by plating
serial dilutions on TSA. Six week old C57Bl/6 mice (10
mice with each isolate) (Jackson labs) were sedated with
ketamine and xylazine, after which they were inoculated
with 20 μl of the bacterial preparation. Four hours after
inoculation, 5 mice from each group were euthanized by
forced CO2 inhalation. The lungs were removed aseptic-
ally and placed in RNAprotect.
cDNA generation and qPCR assays
qPCR plates were prepared using 1:10 dilutions of a
combined stock of forward and reverse primers at a final
concentration of 1.25 μM (Invitrogen). 10 μl of diluted
0.125 μM primers was dispensed in quadruplicate to
384-well plates and were subsequently dried. cDNA
samples were generated using the overnight method de-
scribed above to generate probes for microarray experi-
ments without the use of aa-dUTP. 10 ng of each
sample was then combined with 2.5 μl of 2X SYBR
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http://www.biomedcentral.com/1471-2164/15/1145Green Master Mix (Roche) to a total reaction volume of
5 μl per well. Median Crossing point (Cp) values for the
qPCR quadruplicate reactions were calculated. The rela-
tive expression changes for each gene were calculated by
ΔΔCp normalization based on 4 control genes
(SAUSA300_0175, SAUSA300_2543, SAUSA300_2001
and SAUSA300_1747). To determine fold change, the
normalized Cp values of USA300 and USA400 gene ex-
pression were used to calculate the ΔΔCp during in vivo
growth. The difference of the gene expression was
regarded as significant when ΔΔCp ≥1 or ≤ −1 (>2-fold).Availability of supporting data
All microarray gene expression data is publicly available
at GEO at the NCBI (GenBank) under GSE26255. All
454 sequencing data may be found in the short read
achieve (SRA: http://www.ncbi.nlm.nih.gov/sra/).Additional files
Additional file 1: Table S1. Gene unique to USA300 lineage compared
to USA400 isolates by PanGenome analysis by PanOct.
Additional file 2: Table S2. Gene unique to USA400 lineage compared
to USA300 isolates by PanGenome analysis by PanOct.
Additional file 3: Table S3. PanGenome analysis comparing USA300
and USA400 isolates to other S. aureus sequence types. A “1” designation
indicates presence of a gene and a “0” indicates absence.
Additional file 4: Table S4. Table of genes, based on a p values
≤0.001, that support the 2 major branches. Analysis of these genes
reveals a significant number of conserved hypothetical genes. These
genes appear to be associated with bacteriophage and mobile genomic
elements present in USA300 that are absent in the USA400 lineages.
Additional file 5: Table S5. Table of SNPs identified by kSNP analysis
resulting is clustering of S. aureus isolates by sequence type.
Additional file 6: Figure S1. PanGenome Analysis of USA300 and
USA400 lineages compared to other S. aureus Sequence-types. A
pan-genome analysis of Staphylococcus aureus genomes was done using
PanOCT v 2.1 to generate clusters of orthologous genes. This was a broad
representation of Staphylococcus aureus genomes that included several
representatives of USA300 and USA400 sequence types. Green icons
indicate USA300 isolates and red icons indicate USA400 isolates.
Additional file 7: Figure S2. kSNP analysis of USA300 and USA400
isolates. Single Nucleotide Polymorphism (SNP) analysis was done and
phylogenetic trees were created using the software package kSNP v2.1.2.
Staphylococcus aureus subsp. aureus USA300_FPR3757 (CP000255.1) was
the USA300 reference and Staphylococcus aureus subsp. aureus MW2
(NC_003923.1) was the USA400 reference. Red coloring represent USA300
isolates and green shading represent USA400 isolates.
Additional file 8: Table S6. Genes encoded in prophage ΦSa2usa
annotated in the USA300 genome were profiled for differential expression
compared to USA400 isolate 649 during in vitro and in vivo growth. Negative
values (green shading) represent genes higher expressed in the USA400
isolate compared to the USA300. Positive values (red shading) represent
genes higher expressed in the USA300 isolate compared to the USA400
isolate. #N/A indicates no expression ratio was obtained. Vales are log2.
Additional file 9: Table S7. Genes encoded in prophage ΦSa3usa
annotated in the USA300 genome were profiled for differential expression
compared to USA400 isolate 649 during in vitro and in vivo growth. Negative
values (green shading) represent genes higher expressed in the USA400
isolate compared to the USA300. Positive values (red shading) representgenes higher expressed in the USA300 isolate compared to the USA400
isolate. #N/A indicates no expression ratio was obtained. Vales are log2.
Additional file 10: Table S8. Genes involved in neutrophil evasion as
annotated in the USA300 genome, were profiled for differential expression
compared to USA400 isolate 649 during in vitro and in vivo growth. Negative
values (green shading) represent genes higher expressed in the USA400
isolate compared to the USA300. Positive values (red shading) represent
genes higher expressed in the USA300 isolate compared to the USA400
isolate. #N/A indicates no expression ratio was obtained. Vales are log2.
Additional file 11: Table S9. Genes encoded in pathogenicity islands
vSAα and vSAβ, as annotated in the USA300 genome, were profiled for
differential expression compared to USA400 isolate 649 during in vitro and
in vivo growth. Negative values (green shading) represent genes higher
expressed in the USA400 isolate compared to the USA300. Positive values
(red shading) represent genes higher expressed in the USA300 isolate
compared to the USA400 isolate. #N/A indicates no expression ratio was
obtained. Vales are log2.Competing interests
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